What top creators are saying about Insilico Medicine(INSILICO_PRIVATE)

A private artificial intelligence company specializing in AI for drug discovery and development.

2 AI-extracted insights from 2 sources — podcasts, YouTube channels, and X/Twitter accounts.

Creator sentiment — last 30 days

Not enough scored insights about Insilico Medicine in the last 30 days yet.

Top creators covering Insilico Medicine (INSILICO_PRIVATE)

The 2 sources with the most insights about Insilico Medicine on Kazuha.

Latest insights about Insilico Medicine (INSILICO_PRIVATE)

AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.

Tuesday, April 14, 2026

Very Bullish
Target: None

Has 28 AI-discovered drugs in its pipeline and is showing success in clinical trial phases through AI optimization.

Friday, January 2, 2026

Very Bullish

Highlighted as a prime example of a company successfully applying AI to a specific, high-value industry (drug discovery), which can dramatically speed up clinical trials.

Discussed alongside Insilico Medicine (INSILICO_PRIVATE)

Other assets that creators frequently mention in the same content as Insilico Medicine.

Frequently asked

Which podcasters and creators cover Insilico Medicine (INSILICO_PRIVATE) the most?

The most active sources covering Insilico Medicine (INSILICO_PRIVATE) on Kazuha are @peterdiamandis, PHD Ventures. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.

How many insights about Insilico Medicine (INSILICO_PRIVATE) are on Kazuha?

Kazuha has indexed 2 AI-extracted insights about Insilico Medicine (INSILICO_PRIVATE) from 2 different sources. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.

What other assets do creators discuss alongside Insilico Medicine (INSILICO_PRIVATE)?

Creators covering Insilico Medicine (INSILICO_PRIVATE) most frequently also discuss NVDA, LLY, PRIVATE, AMZN, PRE-IPO. See the "Discussed alongside" section above for full asset pages.